Furthermore, it has been recently reported that RRx-001 ameliorates systemic inflammation by inhibiting the assembly of NLRP3 inflammasome in mice with colitis and experimental autoimmune encephalomyelitis (EAE) (Chen et al., 2021). Here, NLRP3 is linked to colitis.